Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke

Abstract Background Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resi...

Full description

Bibliographic Details
Main Authors: Qi Zhou, Hongyi Yan, Aoming Jin, Xia Meng, Jinxi Lin, Hao Li, Yongjun Wang, Yuesong Pan
Format: Article
Language:English
Published: BMC 2023-12-01
Series:Diabetology & Metabolic Syndrome
Subjects:
Online Access:https://doi.org/10.1186/s13098-023-01235-2
_version_ 1797414394771013632
author Qi Zhou
Hongyi Yan
Aoming Jin
Xia Meng
Jinxi Lin
Hao Li
Yongjun Wang
Yuesong Pan
author_facet Qi Zhou
Hongyi Yan
Aoming Jin
Xia Meng
Jinxi Lin
Hao Li
Yongjun Wang
Yuesong Pan
author_sort Qi Zhou
collection DOAJ
description Abstract Background Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Methods Patients with ischemic stroke without a history of diabetes mellitus in the Third China National Stroke Registry were included. Adipose tissue specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 5 groups according to the quintiles. Outcomes included stroke recurrence (ischemic or hemorrhagic), combined vascular events, all-cause death, and poor outcome (modified Rankin Scale, 3–6) at 12 months after stroke onset. We assessed the association between Adipo-IR and risk of prognosis by multivariable Cox/logistic regression models adjusted for potential covariates. Results Among 2,222 patients, 69.0% were men with a mean age of 62.5 years. At 12 months, 185 (8.3%) patients had recurrent stroke, 193 (8.7%) had combined vascular events, 58 (2.6%) died, and 250 (11.5%) had a poor outcome. Compared with patients with the lowest quintile, patients with the second, third, fourth, fifth quintiles of the Adipo-IR were associated with an increased risk of stroke recurrence (hazard ratio [HR], 1.77; 95% CI, 1.04–3.03; P = 0.04; HR, 2.19; 95% CI, 1.30–3.68; P = 0.003; HR, 1.84; 95% CI, 1.06–3.21; P = 0.03; HR, 2.11; 95% CI, 1.20–3.71; P = 0.01, respectively) and marginally associated with an increased risk of combined vascular events ( HR, 1.60; 95%CI, 0.97–2.64; P = 0.07; HR, 1.91; 95% CI, 1.17–3.13; P = 0.01; HR, 1.62; 95% CI, 0.96–2.75; P = 0.07; HR, 1.80; 95% CI, 1.05–3.09; P = 0.03, respectively) at 12 months after adjustment for potential covariates. Adipo-IR was not associated with mortality and poor outcome at 12 months. Conclusions These findings suggest that adipose tissue specific insulin resistance is independently associated with recurrent stroke and combined vascular events after acute ischemic stroke in nondiabetic patients.
first_indexed 2024-03-09T05:32:26Z
format Article
id doaj.art-8efce6aff362405f81090f87d9485ce8
institution Directory Open Access Journal
issn 1758-5996
language English
last_indexed 2024-03-09T05:32:26Z
publishDate 2023-12-01
publisher BMC
record_format Article
series Diabetology & Metabolic Syndrome
spelling doaj.art-8efce6aff362405f81090f87d9485ce82023-12-03T12:31:18ZengBMCDiabetology & Metabolic Syndrome1758-59962023-12-0115111010.1186/s13098-023-01235-2Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic strokeQi Zhou0Hongyi Yan1Aoming Jin2Xia Meng3Jinxi Lin4Hao Li5Yongjun Wang6Yuesong Pan7Department of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical UniversityAbstract Background Insulin resistance is linked to atherosclerotic cardiovascular diseases and stroke, whereas less is known about adipose tissue specific insulin resistance and outcomes after ischemic stroke. This study aimed to estimate the association between adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke. Methods Patients with ischemic stroke without a history of diabetes mellitus in the Third China National Stroke Registry were included. Adipose tissue specific insulin resistance index (Adipo-IR) was calculated by fasting serum insulin and free fatty acids and categorized into 5 groups according to the quintiles. Outcomes included stroke recurrence (ischemic or hemorrhagic), combined vascular events, all-cause death, and poor outcome (modified Rankin Scale, 3–6) at 12 months after stroke onset. We assessed the association between Adipo-IR and risk of prognosis by multivariable Cox/logistic regression models adjusted for potential covariates. Results Among 2,222 patients, 69.0% were men with a mean age of 62.5 years. At 12 months, 185 (8.3%) patients had recurrent stroke, 193 (8.7%) had combined vascular events, 58 (2.6%) died, and 250 (11.5%) had a poor outcome. Compared with patients with the lowest quintile, patients with the second, third, fourth, fifth quintiles of the Adipo-IR were associated with an increased risk of stroke recurrence (hazard ratio [HR], 1.77; 95% CI, 1.04–3.03; P = 0.04; HR, 2.19; 95% CI, 1.30–3.68; P = 0.003; HR, 1.84; 95% CI, 1.06–3.21; P = 0.03; HR, 2.11; 95% CI, 1.20–3.71; P = 0.01, respectively) and marginally associated with an increased risk of combined vascular events ( HR, 1.60; 95%CI, 0.97–2.64; P = 0.07; HR, 1.91; 95% CI, 1.17–3.13; P = 0.01; HR, 1.62; 95% CI, 0.96–2.75; P = 0.07; HR, 1.80; 95% CI, 1.05–3.09; P = 0.03, respectively) at 12 months after adjustment for potential covariates. Adipo-IR was not associated with mortality and poor outcome at 12 months. Conclusions These findings suggest that adipose tissue specific insulin resistance is independently associated with recurrent stroke and combined vascular events after acute ischemic stroke in nondiabetic patients.https://doi.org/10.1186/s13098-023-01235-2Adipose tissueInsulin resistanceMetabolismRiskStroke
spellingShingle Qi Zhou
Hongyi Yan
Aoming Jin
Xia Meng
Jinxi Lin
Hao Li
Yongjun Wang
Yuesong Pan
Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
Diabetology & Metabolic Syndrome
Adipose tissue
Insulin resistance
Metabolism
Risk
Stroke
title Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_full Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_fullStr Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_full_unstemmed Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_short Adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
title_sort adipose tissue specific insulin resistance and prognosis of nondiabetic patients with ischemic stroke
topic Adipose tissue
Insulin resistance
Metabolism
Risk
Stroke
url https://doi.org/10.1186/s13098-023-01235-2
work_keys_str_mv AT qizhou adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT hongyiyan adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT aomingjin adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT xiameng adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT jinxilin adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT haoli adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT yongjunwang adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke
AT yuesongpan adiposetissuespecificinsulinresistanceandprognosisofnondiabeticpatientswithischemicstroke